These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 4027622)

  • 1. Systemic and nigral application of amphetamine both cause an increase in extracellular concentration of ascorbate in the caudate nucleus of the rat.
    Wilson RL; Wightman RM
    Brain Res; 1985 Jul; 339(2):219-26. PubMed ID: 4027622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unilateral, intranigral infusions of amphetamine produce differential, bilateral changes in unit activity and extracellular levels of ascorbate in the neostriatum of the rat.
    Wilson RL; Kamata K; Wightman RM; Rebec GV
    Brain Res; 1986 Oct; 384(2):342-7. PubMed ID: 3779385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of the unilateral nigral application of dopaminergic drugs on the in vivo release of dopamine in the two caudate nuclei of the cat.
    Nieoullon A; Cheramy A; Leviel V; Glowinski J
    Eur J Pharmacol; 1979 Jan; 53(3):289-96. PubMed ID: 32060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for a direct action of amphetamine on dopamine metabolism in the rat substantia nigra in vivo.
    Argiolas A; Fadda F; Stefanini E; Gessa GL
    Naunyn Schmiedebergs Arch Pharmacol; 1978; 301(3):171-4. PubMed ID: 634376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of haloperidol on amphetamine-induced increases in ascorbic acid and uric acid as determined by voltammetry in vivo.
    Mueller K; Haskett C
    Pharmacol Biochem Behav; 1987 Jun; 27(2):231-4. PubMed ID: 3628437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo voltammetry with electrodes that discriminate between dopamine and ascorbate.
    Ewing AG; Wightman RM; Dayton MA
    Brain Res; 1982 Oct; 249(2):361-70. PubMed ID: 6814706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurochemical changes in the substantiae nigrae and caudate nuclei following acute unilateral intranigral infusions of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Sirinathsinghji DJ; Whittington PE; Audsley AR
    Brain Res; 1986 Dec; 399(2):339-45. PubMed ID: 2435361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repeated administration of high doses of amphetamine increases release of ascorbic acid in caudate but not nucleus accumbens.
    Mueller K
    Brain Res; 1989 Aug; 494(1):30-5. PubMed ID: 2765922
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decrease in neostriatal blood flow after D-amphetamine administration or electrical stimulation of the substantia nigra.
    Lavyne MH; Koltun WA; Clement JA; Rosene DL; Pickren KS; Zervas NT; Wurtman RJ
    Brain Res; 1977 Oct; 135(1):77-86. PubMed ID: 410481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crus cerebri lesions abolish amphetamine-induced ascorbate release in the rat neostriatum.
    Wilson RL; Kamata K; Bigelow JC; Rebec GV; Wightman RM
    Brain Res; 1986 Apr; 370(2):393-6. PubMed ID: 3518863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corticostriatal and thalamic regulation of amphetamine-induced ascorbate release in the neostriatum.
    Basse-Tomusk A; Rebec GV
    Pharmacol Biochem Behav; 1990 Jan; 35(1):55-60. PubMed ID: 2315370
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Release of acetylcholinesterase and aminopeptidase in vivo following infusion of amphetamine into the substantia nigra.
    Greenfield SA; Shaw SG
    Neuroscience; 1982; 7(11):2883-93. PubMed ID: 7155357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of naloxone on dopamine release in the nigrostriatal system.
    Daudet F; Leviel V; Kerny C; Guibert B; Barberis C
    Eur J Pharmacol; 1983 Nov; 95(3-4):199-205. PubMed ID: 6317411
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concomitant sensitization of amphetamine-induced behavioral stimulation and in vivo dopamine release from rat caudate nucleus.
    Patrick SL; Thompson TL; Walker JM; Patrick RL
    Brain Res; 1991 Jan; 538(2):343-6. PubMed ID: 2012977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nocturnal rotation in normal rats: correlation with amphetamine-induced rotation and effects of nigrostriatal lesions.
    Glick SD; Cox RD
    Brain Res; 1978 Jul; 150(1):149-61. PubMed ID: 566609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amphetamine-stimulated release of endogenous dopamine from the rat caudate nucleus in vivo.
    Philips SR; Robson AM
    Neurochem Res; 1983 Jun; 8(6):731-41. PubMed ID: 6621771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Release of endogenously synthesized catechols from the caudate nucleus by stimulation of the nigro-striatal pathway and by the administration of d-amphetamine.
    Chiueh CC; Moore KE
    Brain Res; 1973 Feb; 50(1):221-5. PubMed ID: 4690549
    [No Abstract]   [Full Text] [Related]  

  • 18. Does amphetamine preferentially increase the extracellular concentration of dopamine in the mesolimbic system of freely moving rats?
    Robinson TE; Camp DM
    Neuropsychopharmacology; 1990 Jun; 3(3):163-73. PubMed ID: 1694669
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methylxanthine effects on caudate dopamine release as measured by in vivo electrochemistry.
    Morgan ME; Vestal RE
    Life Sci; 1989; 45(21):2025-39. PubMed ID: 2601563
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereotyped behaviour patterns and hyperactivity induced by amphetamine and apomorphine after discrete 6-hydroxydopamine lesions of extrapyramidal and mesolimbic nuclei.
    Castall B; Marsden CD; Naylor RJ; Pycock CJ
    Brain Res; 1977 Mar; 123(1):89-111. PubMed ID: 300267
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.